4.6 Article

Cessation of asthma medication in early pregnancy

Journal

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
Volume 195, Issue 1, Pages 149-153

Publisher

MOSBY-ELSEVIER
DOI: 10.1016/j.ajog.2006.01.065

Keywords

asthma; pregnancy; medicaid database; drug utilization; guidelines

Funding

  1. AHRQ HHS [U18-HS10384] Funding Source: Medline
  2. NCRR NIH HHS [MO1 RR00095] Funding Source: Medline
  3. NHLBI NIH HHS [UO1 HL 72471] Funding Source: Medline
  4. NIAID NIH HHS [KO8 AI01582] Funding Source: Medline

Ask authors/readers for more resources

Objective: The objective of the study was to determine whether women alter their use of asthma medications during pregnancy. Study design: Weekly asthma medication use was determined from prescription claims data in a cohort of 112,171 pregnant women aged 15 to 44 years who were continuously enrolled in the Tennessee Medicaid program prior to their singleton pregnancy and who delivered a singleton birth during 1995 to 2001. Change in asthma medication use was evaluated using generalized estimating equation analyses. Results: Women with asthma significantly (P <= 0.0005) decreased their asthma medication use from 5 to 13 weeks of pregnancy., During the first trimester, there was a 23% decline in inhaled corticosteroid prescriptions, a 13% decline in short-acting beta-agonist prescriptions, and a 54% decline in rescue corticosteroid prescriptions. Conclusions: Utilization of all categories of asthma medications decreased in early pregnancy, with the largest declines occurring for inhaled and rescue corticosteroids. (c) 2006 Mosby, Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available